IRB Advisor – May 1, 2010
May 1, 2010
View Issues
-
Navigators: Liaisons guide families through informed consent
When a family is adrift on the unfamiliar waters of pediatric research, it helps to have a guide and translator. -
Parents of ill babies make tough choices
The stress of dealing with a critically ill newborn did not prevent parents from making informed decisions about enrolling their child in research, according to a study conducted using a common competence assessment tool. -
Conferences: Overcoming a failure to communicate
The quote above is a familiar truism of human subjects protection. Nevertheless, many institutions still spend a lot of time grappling with the documentation of informed consent and precious little looking at how well the process of informed consent actually informs and prepares subjects for making a decision about research participation. -
Voice of patients missing in adverse event reporting
Rather than blind, call it a "deaf spot." The adverse event reporting from clinical trials that helps inform conclusions about a drug's safety has a crucial hole in it the voices of actual patients taking the drug. -
Simplifying forms can save staff time, improve quality
One issue regarding IRB submission compliance that often is overlooked has to do with the complexity of IRB forms. -
Compliance Corner: Audit helps pinpoint problems with IRB's electronic system
Electronic IRB systems can be an efficient way to improve human subjects research compliance, but as one institution has found, these also can be a source of compliance problems. -
Nurture input from community members
The protocol review discussion will benefit greatly from the questions and input of IRB community members. But this resource too often is underdeveloped as the scientific experts on a board dominate discussions. -
Study finds way to improve community research partnerships
A recent study details strategies for improving community-based participatory research (CBPR) partnerships by training local leaders in research practices and human subjects research protection.